News & Media

Recent updates from Arcutis.

June 6, 2019

Arcutis, Inc. Appoints Scott Burrows as Vice President, Finance

June 3, 2019

Arcutis Announces Initiation of Phase 2a Clinical Trial of ARQ-151 as a Potential Topical Treatment for Atopic Dermatitis

May 30, 2019

Arcutis, Inc. to Present at the Jefferies 2019 Global Healthcare Conference

May 21, 2019

Arcutis, Inc. Appoints John W. Smither as Chief Financial Officer

May 16, 2019

Arcutis, Inc.’s ARQ-151 Development Program for Atopic Dermatitis

May 9, 2019

Arcutis, Inc. to Present at RBC Capital Markets 2019 Healthcare Conference

May 7, 2019

Arcutis, Inc.’s ARQ-151 Development Program for Plaque Psoriasis

April 30, 2019

Arcutis, Inc. Announces Board of Directors

April 23, 2019

Arcutis, Inc. Founded to Address Gap in Immuno-Dermatology Drug Development

Media Resources

Corporate Fact Sheet

Uncovering Psoriasis

Journal of the American Medical Association Roflumilast Cream 0.3% Result

Media Contact

Amanda Sheldon

805.418.5006
media@arcutis.com

Meaningful innovation at a glance.

Download our corporate fact sheet.

Download